Neudle.com: striatal necrosis

Differential
(Click to cross reference)

abortion, spontaneous

abulia

acanthocytosis

aciduria

acquired immunodeficiency syndrome

addiction, heroin

addiction, heroin-neurologic complications with

advances in neurology

adverse drug reaction

affect, flat

agitation

agraphia

Aicardi-Goutieres syndrome

AMPA receptor antibodies

amyotrophic chorea-acanthocytosis

anemia

aneurysm, intracranial

anosmia

anoxia

anti basal ganglia antibodies

anti GQ1b IgG antibody

anti Hu antibody

anti JC virus antibodies

anti-dopamine 2 receptor antibody

antistreptolysin titer

antiviral agents

aortic valve, lesion of

atheromatous branch disease, intracranial

athetosis

attention deficit disorder with hyperactivity

attention span

autoantibodies

autoimmune basal ganglia encephalitis

autoimmune disease

autoimmune GFAP astrocytopathy

autonomic dysfunction

axonal degeneration

azathioprine

B cell lymphocyte depletion

B cell lymphocytes

bacterial infection

bacterial infection, CNS

ballismus, bilateral

basal ganglia

basal ganglia, calcification of

basal ganglia, degeneration

basal ganglia, hemorrhage

basal ganglia, hemorrhage, bilateral

basal ganglia, infarction

basal ganglia, lesion of

basal ganglia, lesion, bilateral

behavioral disorder

behavioral disorder, acute

biotin deficiency, juvenile form

biotin-responsive basal ganglia disease

blacks

blepharospasm

blindness

blood dyscrasias, neurologic findings with

brain biopsy, false negative

brain biopsy, negative

brain transplantation

calcification, intracranial

calcification, intracranial, rim

calmodulin kinase-like vesicle-associated protein

candida albicans

carbon monoxide poisoning

cardiac arrest and resuscitation

cardiomyopathy

carotid artery occlusion, neck-external and internal art patency with

CAT scan

CAT scan, abnormal

CAT scan, contrast enhanced

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, false negative

catatonia

caudate nucleus

caudate nucleus, atrophy

caudate nucleus, hemorrhage of

caudate nucleus, infarction

caudate nucleus, lesion of

caudate nucleus, lesion of, bilateral

CD4 counts

central nervous system, infection of

central pontine myelinolysis

cerebellar atrophy, primary

cerebellar lesion

cerebral blood flow

cerebral cortex

cerebral cortical atrophy

cerebral embolism

cerebral glucose metabolism

cerebral hypersensitivity, delayed

cerebral infarction

cerebral infarction, subcortical

cerebral ischemia

cerebral palsy

cerebral palsy, associated problems with

cerebral venous thrombosis, deep

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrovascular accident

cerebrovascular accident, etiology

cerebrovascular accident, mimics

cerebrovascular accident, secondary prevention

cerebrovascular accident, young adult

ceruloplasmin, serum

chemotherapy, CNS treatment and complications with

chest pain

chest x-ray, abnormal

choreoathetosis, paroxysmal

chromosomal abnormality

Clinical Pathologic Conference(C.P.C.)

collapsin response mediator protein 5 IgG

coma

complications

confusion

congestive heart failure

conjunctival biopsy

controversies in neurology

conus medullaris, lesion of

cop 1

copper metabolism, abnormal

creatine phosphokinase(CPK)elevated

Creutzfeldt-Jakob disease, genetic

cultured skin fibroblasts

cytomegalovirus infection

dementia, rapidly progressive

demyelinating disease

dentate nuclei, lesion of

dermatomyositis

diabetes mellitus

diabetes mellitus, neurologic manifestations of

diabetic ketoacidosis

diabetic striatopathy

diagnostic criteria

dialysis

diarrhea

differential diagnosis

diplegia, spastic cerebral

disability rating scale, neurological

disability, neurological

disease modifying agents

disulfiram

dopa responsive dystonia

dopamine

dopamine receptor

dopamine receptor, D2

DPPX, antibodies, encephalitis

drooling

drug abuse

drug holiday

drug induced neurologic disorders

dyskinesia, buccal lingual facial

dystonia, delayed onset

dystonia, face

dystonia, focal

dystonia, painful

dystonia, post traumatic

dystonia, symptomatic

dystonic reaction, acute

echocardiogram

efficacy

ejection fraction

ejection fraction, abnormal

electroencephalogram

electroencephalogram, abnormalities of

electroencephalogram, periodic complexes

electron microscopy

encephalitis

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, etiology

encephalitis, human immunodeficiency virus type 1

encephalitis, paraneoplastic

encephalitis, viral

encephalomyelitis

encephalomyelitis, parainfectious

encephalomyelitis, postinfectious

encephalopathy

encephalopathy, acute necrotizing

encephalopathy, acute necrotizing of childhood

encephalopathy, anoxic

encephalopathy, parainfectious

encephalopathy, post anoxic

encephalopathy, progressive

endocarditis

enzyme, defect

eosinophilia

epidemiology of neurology

Epstein-Barr virus, negative

evidence-based research

executive dysfunction

external capsule

eye movement, disorders of

faciobrachial dystonic seizure

frontal lobe, anatomy and physiology

fumarate

fungal infection, CNS

gadolinium

gait disorder

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

gaze palsy

gaze palsy, horizontal

genetic neurologic disorders

GFAP gene

GFAP-IgG

globus pallidus

globus pallidus, hemorrhage

globus pallidus, lesion of

globus pallidus, lesion of, bilateral

GLUT1 deficiency syndrome

glutamic acid decarboxylase, antibody

glutaric acidemia

glutaric aciduria

gray matter

Guillain Barre syndrome

gyrus, abnormal

Hallervorden Spatz disease

heavy metal intoxication

hemorrhage, putamenal

hepatic failure

hepatitis

hepatolenticular degeneration(Wilson's disease)

hepatolenticular degeneration, non-Wilsonian

heralding manifestation

herpes simplex encephalitis

Heubner's artery

highly active antiretroviral therapy

hippocampus

hippocampus, hyperintense

Hispanics

Hodgkin's disease

human immunodeficiency virus type 1

Huntington's chorea

Huntington's chorea, akinetic-rigid form

Huntington's chorea, presymptomatic detection of

Huntington's disease, children

hydrocephalus

hyperekplexia

hyperglycemia

hyperglycemia, neurologic dysfunction associated with

hyperglycemia, nonketotic

hypersensitivity reaction

hypertension

hypertonia

hypoglycemia

hypoglycemia, newborn and infant

hypotension, systemic

hypoxia

hypoxia, newborn

hypoxic encephalopathy

iatrogenic neurologic disorders

idiopathic thrombocytopenic purpura

imbalance

immune reconstitution inflammatory syndrome

immunohistochemistry

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

in situ hybridization

inborn errors of metabolism

inclusion bodies

incontinence, fecal

infantile bilateral striatal necrosis

insular cortex, lesion

insular cortex, lesion, bilateral

intellectual deficit

intellectual deterioration

intracerebral hemorrhage

intracerebral hemorrhage, bilateral

intracerebral hemorrhage, causes of

intracerebral hemorrhage, differential diagnosis of

intracerebral hemorrhage, lobar

intracerebral hemorrhage, multiple

intracerebral hemorrhage, young adult

intrauterine

iron, brain

irritability

Jakob-Creutzfeldt disease

JC virus

Kayser-Fleischer ring

lactic acidemia

lactic dehydrogenase(LDH)

lacunar infarction

laminar necrosis, cortical

laquinimod

lead and the nervous system

lead poisoning

learning disability, in children

leg numbness

leg weakness, bilateral

Leigh's disease

Leigh's disease, adult variety

lenticular nucleus, infarction

lenticular nucleus, lesion of

lenticular nucleus, lesion of, bilateral

lenticulostriate arteries

Lesch-Nyhan syndrome

leucine rich glioma inactivated 1 antibodies

leukemia

leukemia, neurologic findings assoc.with

leukocytosis

leukoencephalopathy

leukopenia

level of consciousness, decreased

limbic encephalitis

listeria monocytogenes

liver disease

liver function enzymes

lymphoma

lymphoma involving CNS

lymphoma, primary of CNS

magnetic susceptibility

malformation, vascular

malformation, vascular, cerebral

malignancy screen

mammillary bodies

marche a petits pas

medication withdrawal

MELAS syndrome

memory, defect of recent

memory, impairment of

meningeal enhancement

mental status, abnormal

mesial temporal lobe

methanol intoxication

microinfarcts

midbrain

midbrain, lesion of

middle cerebral artery territory infarction

mimics

Mini Mental Status Examination

misdiagnosis

mitochondrial disease

mitoxantrone

molecular genetics

monoclonal antibodies

mortality

movement disorder

movement disorder, delayed onset

movement disorder, drug induced

movement disorder, extrapyramidal

MRI, CAT scan compared to

MRI, contrast enhanced

MRI, demyelinating disease

MRI, diffusion weighted

MRI, disappearing lesion on

MRI, false negative

MRI, FLAIR

MRI, gradient-echo

MRI, high signal foci on

MRI, high signal intensity of basal ganglia

MRI, hypointense signal foci on

MRI, indications for

MRI, negative

MRI, paramagnetic effect

MRI, punctate pattern

MRI, serial

MRI, spinal cord

MRI, susceptibility weighted

MRI, T1 weighted high signal foci

multiple sclerosis, asymptomatic

multiple sclerosis, children

multiple sclerosis, diagnosis of

multiple sclerosis, differential diagnosis of

multiple sclerosis, disability status scale

multiple sclerosis, disease activity

multiple sclerosis, pathogenesis

multiple sclerosis, plaque

multiple sclerosis, relapsing

multiple sclerosis, treatment of

multiple system atrophy

myasthenia gravis

myasthenia gravis, drug induced

mycoplasma

mycoplasma pneumoniae

mycotoxin

myelinolysis, extrapontine

myelitis

myelitis, autoimmune

myelitis, longitudinal

myelitis, transverse, recurrent

natalizumab, discontinuation

nausea and vomiting

negative

neglect

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS, hemorrhagic

neoplasm, peripheral nerve

neoplasm, primary of CNS

neoplastic angioendotheliosis

neurexin-3 alpha antibodies

neurofibromatosis 1

neurofilament light chain protein

neurologic complications

neurologic complications of, systemic disease

neurologic disease, diagnoses of

neuromyelitis optica (Devic's disease)

neuronal cell surface antigen

neuronal ceroid-lipofuscinosis

neuropathology

neuropathology, brain

neuropathy

neuropathy, iatrogenic

neuropathy, immune

neuropathy, medication induced

neuropathy, motor, multifocal

neuropathy, peripheral, treatment

next-generation sequencing

nonsteroidal anti-inflammatory drug

nutritional deficiency

nystagmus

obsessive-compulsive disorder

occupational neurologic disorders

opportunistic infection

opportunistic infection, CNS

opsoclonus-myoclonus syndrome

optic atrophy

optic nerve, lesion of

optic neuropathy

optic neuropathy, toxic

osmotic demyelination syndrome

Parkinson disease, arteriosclerotic

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, drug induced

Parkinsonism multiple-system atrophy

Parkinsonism syndrome

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

pentoxifylline

periaqueductal lesion

perineural invasion

persistent vegetative state

personality change

photophobia

photosensitivity, skin

pituitary

plasmapheresis

pleocytosis of cerebrospinal fluid

poison, neurologic problems with

poliomyelitis-like illness

polymerase chain reaction

polymerase chain reaction, false negative

polymyositis

polyneuropathy, chronic inflammatory demyelinating

pons, lesion of

posterior leukoencephalopathy syndrome

postpartum

potassium channel antibodies

potassium chlorate

practice guidelines

precipitating factors

pregnancy, neurologic complications in

prevention of neurologic disorders

prion disease

prognosis

progressive multifocal leucoencephalopathy

progressive neurologic disorder

protein 14-3-3, cerebrospinal fluid

psychiatric problems in neurologic disorders

psychological testing

psychosis

ptosis

ptosis, unilateral

pulmonary infiltrates

putamen, lesion of

putamen, lesion of, bilateral

quality of life

radiation therapy, CNS treatment and complications with

radiation therapy, total body

rapidly progressing neurologic illness

rash

recurrent

remote effect of cancer on the nervous system

renal cell carcinoma

respiratory tract infection

retina, abnormal

retinitis pigmentosa

reversible neurologic disorder

risk-benefit assessment

serologic testing, false negative

seronegative

seropositive

single photon emission computed tomography

skin, biopsy

skin, lesions in neurologic disorders

sleep pathology and physiology

spinal cord, enlargement

spinocerebellar ataxia type 1

splenectomy

spongy degeneration of brain

status marmaratus

steroid

steroid responsive encephalopathy

steroid therapy, CNS treatment and complications with

stiff legs

strangulation

streptococcal infection

striatal encephalitis

striatocapsular infarction

striatonigral degeneration

striatum, lesion of

striatum, lesion of, bilateral

subacute sclerosing panencephalitis(S.S.P.E.)Dawson's disease

symmetric brain lesions

systemic illness

systemic lupus erythematosus

systemic lupus erythematosus, neurologic complications with

T cell lymphocytes

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

thalamus, lesion of-bilateral

thiamine

thiamine deficiency

third ventricle, wall

torticollis, post traumatic

toxic encephalopathy

toxins, nervous system

trauma

treatment of neurologic disorder

tremor

tuberous sclerosis

tumor necrosis factor

tumor necrosis factor inhibitor

unconsciousness

uremia

uremic encephalopathy

urinary incontinence

urinary tract infection

vaccination, neurologic complications with

Virchow-Robin spaces, dilated

vision, blurred

vision, failure of in childhood

visual acuity

visual acuity, decreased

visual loss

visual loss, progressive

visual loss, slow

vitamin deficiency

walking frame

walking, difficulty with

weakness

weight loss

Wernicke's encephalopathy

West Nile fever

wheelchair

white matter disease

white matter disease, periventricular

white matter disease, subcortical

wide based gait

workup

xerophthalmia

Showing articles 650 to 700 of 1336 << Previous Next >>

Fatal Myositis Due to the Microsporidian Brachiola algerae, a Mosquito Pathogen
NEJM 351:42-47, Coyle,C.M.,et al, 2004

Radiosurgery for Cerebral Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia
Neurol 63:367-369, Maarouf,M.,et al, 2004

Chemotherapy as Initial Treatment in Gliomatosis Cerebri
Neurol 63:354-356, Levin,N.,et al, 2004

New Diagnostic Criteria for Multiple Sclerosis
Neurol 60:27-30,6, Tintore,M.,et al, 2003

Primary Brain Tumours in Adults
Lancet 361:323-331, Behin,A.,et al, 2003

Interferons in Relapsing Remitting Multiple Sclerosis: A Systematic Review
Lancet 361:545-552, Filippini,G.,et al, 2003

Bilateral Anterior Toxic Optic Neuropathy and the Use of Infliximab
BMJ 326:579, ten Tusscher,M.P.M.,et al, 2003

Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003

Clinical Importance of Neutralising Antibodies Against Interferon Beta in Patients with Relapsing-Remitting Multiple Sclerosis
Lancet 362:1184-1191, Sorensen,P.S.,et al, 2003

Cardiac Troponin Levels Following Monitored Epileptic Seizures
Neurol 60:1690-1692, Woodruff,B.K.,et al, 2003

Validation of Diagnositc Magnetic Resonance Imaging Criteria for Multiple Sclerosis and Response to Interferon B1a
Ann Neurol 53:718-724, Barkhof,F.,et al, 2003

Spontaneous Haemorrhage Into Metastatic Brain Tumours After Stereotactic Radiosurgery Using a Linear Accelerator
JNNP 74:908-912, Suzuki,H.,et al, 2003

A Randomized Controlled Study of the Acute and Chronic Effects of Cooling Therapy for MS
Neurol 60:1955-1960, NASA/MS Cooling Study Group, 2003

High- and Low-Risk Profiles for the Development of Multiple Sclerosis Within 10 Years After Optic Neuritis
Arch Ophthalmol 121:944-949, Optic Neuritis Study Group, 2003

Electrocardiographic Changes in Intracranial Hemorrhage Mimicking Myocardial Infarction
NEJM 349:561, Bailey,W.B. &Chaitman,B.T., 2003

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003

Valvular Dysfunction and Carotid, Subclavian, and Coronary Artery Disease in Survivors of Hodgkin Lymphoma Treated with Radiation Therapy
JAMA 290:2831-2837, Hull,M.C.,et al, 2003

The Use of Mitoxantrone (Novantrone) for the Treatment of Multiple Sclerosis
Neurol 61:1332-1338, Goodin,D.S.,et al, 2003

Sucessful Treatment of Radiation-Induced Brain Necrosis by Hyperbaric Oxygen Therapy
J Neurol Sci 209:115-117, Kohshi,K.,et al, 2003

Cerebral Toxoplasmosis Following Etanercept Treatment for Idiophatic Pneumonia Syndrome after Autologous Peripheral Blood Progenitor Cell Transplantation (PBPCT)
Ann Hematol 82:649-653, Gonzalez-Vicent, M.,et al, 2003

Cortical Laminar Necrosis in Brain Infarcts: Serial MRI
Neuroradiology 45:283-288, Siskas, N.,et al, 2003

Brain Metastases from Bladder Carcinoma: Presentation, Treatment and Survival
, Mahmoud-Ahmed, A.S.,et al, 2002

Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002

Mitoxantrone in Progressive Multiple Sclerosis: A Placebo-Controlled, Double-Blind, Randomised, Multicentre Trial
Lancet 360:2018-2025, Hartung,H.,et al, 2002

Copaxone's Effect on MRI-Monitored Disease in Relapsing MS is Reproducible and Sustained
Neurol 59:1284-1286, Wolinsky,J.S.,et al, 2002

Early Onset Multiple Sclerosis
Neurol 59:1006-1010, Boiko,A.,et al, 2002

Treatment of Spinal Epidural Metastasis Improves Patient Survival and Functional State
Neurol 58:1360-1366, Zaidat,O.O &Ruff,R.L., 2002

Multiple Sclerosis
Lancet 359:1221-1231, Compston,A. &Coles,A., 2002

Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS
Neurol 58:1404-1407,1323, Killestein,J.,et al, 2002

Gliomatosis Cerebri: Molecular Pathology and Clinical Course
Ann Neurol 52:390-399,389, Herrlinger,U.,et al, 2002

Therapy-Related Acute Myeloblastic Leukemia After Mitoxantrone Treatment in a Patient with MS
Neurol 59:954-955, Brassat,D.,et al, 2002

Cardiac Adverse Effects Associated with Mitoxantrone (Novantrone) Therapy in Patients with MS
Neurol 59:909-913, Ghalie,R.G.,et al, 2002

Effect of Radiotherapy and Other Treatment-Related Factors on Mid-Term to Long-Term Cognitive Sequelae in Low-Grade Gliomas: A Comparative Study
Lancet 360:1361-1368, Klein,M.,et al, 2002

A Randomized, Double-Blind, Dose-Comparison Study of Weekly Interferon B-1a in Relapsing MS
Neurol 59:1507-1517,1482, Clanet,M.,et al, 2002

Refractory Neurosarcoidosis Responding to Infliximab
Neurol 59:1660-1661, Pettersen,J.A.,et al, 2002

Randomized, Comparative Study of Interferon B-1a Treatment Regimens in MS
Neurol 59:1496-1506,1482, Panitch,H.,et al, 2002

Severe Neurologic Complications After Hematopoietic Stem Cell Transplantation in Children
Neurol 59:1895-1904,E13, Farci,M.,et al, 2002

Radiotherapy-induced Cerebral Abnormalities in Patients with Low-grade Glioma
Neurol 59:121-123,8, Postma,T.J.,et al, 2002

Interferon Beta but not Glatiramer Acetate Therapy Aggravates Headaches in MS
Neurol 59:636-639, Pollmann,W.,et al, 2002

Benefit of Interferon B-1a on MSFC Progression in Secondary Progressive MS
Neurol 59:679-687, Cohen,J.A.,et al, 2002

Efficacy and Safety of Modafinil (Provigil) for the Treatment of Fatigue in Multiple Sclerosis: A Two Centre Phase 2 Study
JNNP 72:179-183,150, Rammohan,K.W.,et al, 2002

Interferon Beta-1a for Early Multiple Sclerosis: CHAMPS Trial Subgroup Analyses
Ann Neurol 51:481-490, Beck,R.W.,et al, 2002

Temporal Arteritis
JAMA 287:2996-3000,3034, Hellmann,D.B., 2002

Application of the New McDonald Criteria to Patients with Clinically Isolated Syndromes Suggestive of Mulitple Sclerosis
Ann Neurol 52:47-53, Dalton,C.M.,et al, 2002

A Multicenter Study of Treatment of Primary CNS Lymphoma
Neurol 58:1513-1520, Ferreri,A.J.M.,et al, 2002

A Longitudinal Study of Abnormalities on MRI and Disability From Multiple Sclerosis
NEJM 346:158-164,199, Brex,P.A.,et al, 2002

Plasma Exchange for Severe Attacks of CNS: Demyelination: Predictors of Response
Neurol 58:143-146, Keegan,M.,et al, 2002

An Open-Label Trial of Combination Therapy With Interferon B-1a and Oral Methotrexate in MS
Neurol 58:314-317, Calabresi,P.A.,et al, 2002

Disease Modifying Therapies in Multiple Sclerosis
Neurol 58:169-178, Goodin,D.S.,et al, 2002

Middle Cerebral Artery Stenosis Is a Major Clinical Determinant in Striatocapsular Small, Deep Infarction
Arch Neurol 59:259-263, Bang,O.Y.,et al, 2002

Showing articles 650 to 700 of 1336 << Previous Next >>